Works matching IS 0008543X AND DT 2020 AND VI 126 AND IP 24


Results: 28
    2
    4
    5
    6
    7
    8

    Predictive classifier for intensive treatment of head and neck cancer.

    Published in:
    2020
    By:
    • Zakeri, Kaveh;
    • Rotolo, Federico;
    • Lacas, Benjamin;
    • Vitzthum, Lucas K.;
    • Le, Quynh‐Thu;
    • Gregoire, Vincent;
    • Overgaard, Jens;
    • Hackshaw, Allan;
    • Zackrisson, Björn;
    • Parmar, Mahesh K. B.;
    • Burtness, Barbara A.;
    • Ghi, Maria Grazia;
    • Sanguineti, Giuseppe;
    • O'Sullivan, Brian;
    • Fortpied, Catherine;
    • Bourhis, Jean;
    • Shen, Hanjie;
    • Harris, Jonathan;
    • Michiels, Stefan;
    • Pignon, Jean‐Pierre
    Publication type:
    journal article
    9
    10
    11

    ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma—A Children's Oncology Group study

    Published in:
    Cancer (0008543X), 2020, v. 126, n. 24, p. 5303, doi. 10.1002/cncr.33195
    By:
    • Geller, James I.;
    • Pressey, Joseph G.;
    • Smith, Malcolm A.;
    • Kudgus, Rachel A.;
    • Cajaiba, Mariana;
    • Reid, Joel M.;
    • Hall, David;
    • Barkauskas, Donald A.;
    • Voss, Stephen D.;
    • Cho, Steve Y.;
    • Berg, Stacey L.;
    • Dome, Jeffrey S.;
    • Fox, Elizabeth;
    • Weigel, Brenda J.
    Publication type:
    Article
    12
    13
    14

    Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3‐arm randomized trial.

    Published in:
    Cancer (0008543X), 2020, v. 126, n. 24, p. 5328, doi. 10.1002/cncr.33186
    By:
    • Dos Santos, Mélanie;
    • Hardy‐Léger, Isabelle;
    • Rigal, Olivier;
    • Licaj, Idlir;
    • Dauchy, Sarah;
    • Levy, Christelle;
    • Noal, Sabine;
    • Segura, Carine;
    • Delcambre, Corinne;
    • Allouache, Djelila;
    • Parzy, Aurélie;
    • Barriere, Jérôme;
    • Petit, Thierry;
    • Lange, Marie;
    • Capel, Aurélie;
    • Clarisse, Bénédicte;
    • Grellard, Jean Michel;
    • Lefel, Johan;
    • Joly, Florence
    Publication type:
    Article
    15

    Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study.

    Published in:
    2020
    By:
    • Soomers, Vicky L. M. N.;
    • Husson, Olga;
    • Desar, Ingrid M. E.;
    • Sande, Michiel A. J.;
    • Haan, Jacco J.;
    • Verhoef, Cornelis;
    • Vriens, Ingeborg J. H.;
    • Houdt, Winan J.;
    • Poll‐Franse, Lonneke;
    • Graaf, Winette T. A.;
    • van de Sande, Michiel A J;
    • de Haan, Jacco J;
    • van Houdt, Winan J;
    • van de Poll-Franse, Lonneke;
    • van der Graaf, Winette T A
    Publication type:
    journal article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Everolimus plus bevacizumab is an effective first‐line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial.

    Published in:
    Cancer (0008543X), 2020, v. 126, n. 24, p. 5247, doi. 10.1002/cncr.33148
    By:
    • Feldman, Darren R.;
    • Ged, Yasser;
    • Lee, Chung‐Han;
    • Knezevic, Andrea;
    • Molina, Ana M.;
    • Chen, Ying‐Bei;
    • Chaim, Joshua;
    • Coskey, Devyn T.;
    • Murray, Samuel;
    • Tickoo, Satish K.;
    • Reuter, Victor E.;
    • Patil, Sujata;
    • Xiao, Han;
    • Aghalar, Jahan;
    • Apollo, Arlyn J.;
    • Carlo, Maria I.;
    • Motzer, Robert J.;
    • Voss, Martin H.
    Publication type:
    Article
    27
    28

    Issue Information.

    Published in:
    Cancer (0008543X), 2020, v. 126, n. 24, p. 5185, doi. 10.1002/cncr.32112
    Publication type:
    Article